✦ LIBER ✦

A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin-2 for metastatic melanoma. Clinical data and immunomonitoring

✍ Scribed by Reinhard Dummer; Günter Burg; Martin E. Gore; Barry W. Hancock; Pierre J. Guillou; Heleen C. Grobben; Ralph Oskam; Jeanne P. Dieleman; Jürgen C. Becker

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 563 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of human recombinant ln

A phase II trial of human recombinant lnterleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study

✍ Madeline Bauer; Gregory H. Reaman; Jacquelyn A. Hank; Mitchell S. Cairo; Peter A 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB